Arcosa (NYSE: ACA) investors overwhelmingly back CRH deal. See how the vote broke down.
Arcosa (ACA) held a special meeting on September 4, 2026, where shareholders overwhelmingly approved a merger agreement with CRH Americas. 80.8% of shares voted, with 99.8% supporting the deal. Shareholders also approved executive compensation related to the merger on an advisory basis.
How this was made
The 30-second read
Why it matters
The merger approval removes a major hurdle, likely triggering a share price increase for ACA and a cash outflow for CRH.
Market read
ACA's merger approval is a primary corporate event with immediate trading implications.
What to watch
Potential for ACA shareholders to demand higher premium if market sentiment shifts.
Background
Arcosa Inc. filed an 8‑K reporting the results of a special shareholder meeting approving its merger with CRH Americas, Inc.
Ticker impact
Arcosa shareholders approved the merger with CRH Americas, clearing a key hurdle for the transaction.
ACA expected to rise on merger completion expectations.
Approval of a merger at 80% quorum removes uncertainty and signals imminent cash or stock consideration.
Market effects
Consolidation in construction materials sector as CRH expands its U.S. footprint.
Potential positive impact on U.S. construction supply chain stocks.
Adds to global M&A activity in building materials, modest worldwide effect.
Counterpoint
Deal could face regulatory scrutiny or integration challenges, weighing on ACA's upside.
Key entities
- companyArcosa, Inc.
U.S. construction materials firm, ticker ACA.
- companyCRH Americas, Inc.
U.S. subsidiary of CRH plc, the merger acquirer.
